GEHC
GE HealthCare Technologies Inc
GE HealthCare Technologies Inc historical holders
total: 7
Pzena Investment Management GE HealthCare Technologies Inc transactions over time
- Total transactions:
- 3
- New positions:
- 1
- Sold out:
- 1
- Reduced:
- 1
- Held since:
- 2023 Q1
- Held for:
- 2 quarters
- Latest activity:
- 2023 Q3
Richard Pzena has been an institutional investor in GE HealthCare Technologies Inc (GEHC) since 2023 Q1. According to 2026 Q2 report, Richard Pzena doesn't hold any shares. The fund/company first acquired GEHC in 2023 Q1, initially purchasing about 3.63M shares. Since the initial investment, Pzena Investment Management has made 2 more transactions in this position.
When did Richard Pzena exit their GEHC position?
Richard Pzena no longer holds GE HealthCare Technologies Inc (GEHC). They sold off their entire position in 2023 Q3, closing out an investment that began in 2023 Q1.
When did Richard Pzena first invest in GEHC?
Richard Pzena first invested in GE HealthCare Technologies Inc (GEHC) in 2023 Q1 at the reported quarter-end price of $82.03 per share, acquiring 3,625,855 shares in their initial purchase.
What is Richard Pzena's average cost basis for GEHC?
Based on historical transaction data, Richard Pzena's estimated cost basis for GE HealthCare Technologies Inc (GEHC) is approximately $82.03 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $82.03
- Weighted AVG sell price:
- $81.24
GEHC transactions history by Pzena Investment Management
3 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2023 Q3
|
0.00%
|
0
|
$81.24
|
|
-100% (-2,573,162)
|
-0.89%
|
|
2023 Q2
|
0.89%
|
2,573,162
|
$81.24
|
$209,043,681
|
-29.03% (-1,052,693)
|
-0.37%
|
|
2023 Q1
|
1.28%
|
3,625,855
|
$82.03
|
$297,428,886
|
new
|
+1.28%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.